SCHEMBL9703578

SCHEMBL9703578

CCn1c(=O)c(C(=O)O)nc2cc(Cl)c(Cl)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
AGTR1 P30556 1/20 0.47
AGTR2 P50052 1/20 0.47
GRIA1 P42261 2/20 0.46
GRIA2 P42262 2/20 0.46
GRIA3 P42263 2/20 0.46
GRIA4 P48058 2/20 0.46
LMNA P02545 2/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GRIK1 P39086 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2A Q12879 1/20 0.46
GRIK2 Q13002 1/20 0.46
GRIK3 Q13003 1/20 0.46
GRIN2B Q13224 1/20 0.46
GRIN2C Q14957 1/20 0.46
GRIK4 Q16099 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9704918 0.84 MAPK1 (0.50) MAPK1CASP1CASP7KDM4ECYP1A2
SCHEMBL9705722 0.82 MAPK1 (0.49) MAPK1CASP1CASP7LMNAKDM4E
SCHEMBL9703964 0.81 MAPK1 (0.58) MAPK1CASP1CASP7LMNAKDM4E
SCHEMBL6606816 0.78 NLRP3 (0.59) MAPK1CASP1CASP7LMNAKDM4E
SCHEMBL9704330 0.78 MAPK1 (0.45) MAPK1CASP1CASP7LMNAKDM4E
SCHEMBL9703943 0.73 CYP1A2 (0.52) MAPK1CASP1CASP7LMNACYP1A2
SCHEMBL1048487 0.73 KDM4E (0.58) LMNAKDM4ECYP1A2MEN1TSHR
SCHEMBL17279262 0.71 KDM4E (0.50) AGTR1AGTR2GRIA1GRIA2GRIA3
SCHEMBL7473048 0.71 KDM4E (0.50) AGTR1AGTR2GRIA1GRIA2GRIA3
SCHEMBL31588826 0.69 CYP2D6 (0.45) AGTR1AGTR2GRIA1GRIA2GRIA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992011245-A1 2-ACYLAMIDO DERIVATIVES OF 3,4-DIHYDRO-3-OXO-QUINOXALINE HAVING PHARMACEUTICAL ACTIVITY WARNER-LAMBERT COMPANY (US) 1992-07-09 WO disclosed
US-4355030-A Antiviral combinations ELI LILLY AND COMPANY (US) 1982-10-19 US disclosed
US-4289773-A ETHYL 6,7-DIBROMO-3,4-DIHYDRO-3-OXOQUINOXALINE CARBOXYLATE AND A HINDERED AMINE ELI LILLY AND COMPANY (US) 1981-09-15 US disclosed
US-4271162-A ETHYL 6,7-DICHLORO-3,4-DIHYDRO-3-ONOQUINOXALINE CARBOXYLATE AND 1-AMINOADAMANTANE ELI LILLY AND COMPANY (US) 1981-06-02 US disclosed
EP-0020836-A1 Antiviral combinations ELI LILLY AND COMPANY (US) 1981-01-07 EP disclosed
US-4210647-A INFLUENZA VIRUS, ETHYL 6,7-DIBROMO-3,4-DIHYDRO-3-OXO-2-QUINOXALINECARBOXYLATE, 1-AMINOADAMANTANE ELI LILLY AND COMPANY (US) 1980-07-01 US disclosed